Issue navigation
Volume 58, Issue 1, 1 January 2012
Introduction
Impact of Biomarkers, Proteomics, and Genomics in Cardiovascular Disease
Fred S Apple and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 1–2, https://doi.org/10.1373/clinchem.2011.175919
Editorials
Growth Differentiation Factor 15: A Canary in a Coal Mine?
Jennifer E Ho and Thomas J Wang
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 3–5, https://doi.org/10.1373/clinchem.2011.175406
Statins, Plasma Proprotein Convertase Subtilisin/Kexin Type 9 Concentrations, and LDL Lowering
Amit Khera
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 6–7, https://doi.org/10.1373/clinchem.2011.176800
Delta Cardiac Troponin Values in Practice: Are We Ready to Move Absolutely Forward to Clinical Routine?
Fred S Apple and David A Morrow
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 8–10, https://doi.org/10.1373/clinchem.2011.175414
Interview
An Interview with Dr. Eugene Braunwald
Misia Landau
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 11–20, https://doi.org/10.1373/clinchem.2011.165845
Reflection
Reflections on the Evolution of Cardiac Biomarkers
Jack H Ladenson
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 21–24, https://doi.org/10.1373/clinchem.2011.165852
Perspectives
A Novel Technology for Measuring Cumulative Cardiac Biomarker Exposure over Time: What Happened When We Weren't Looking?
Christopher deFilippi
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 25–27, https://doi.org/10.1373/clinchem.2011.175158
Within Sight of a Rational Pipeline for Development of Protein Diagnostics
Leigh Anderson
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 28–30, https://doi.org/10.1373/clinchem.2011.173377
Q&A
The Challenges and Concerns Companies Face Pertaining to the US Food and Drug Administration 510(k) Process for Cardiac Biomarkers
Fred S Apple and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 31–38, https://doi.org/10.1373/clinchem.2011.165860
Clinical Case Study
Interpreting Changes in Troponin—Clinical Judgment Is Essential
Hugo A Katus and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 39–43, https://doi.org/10.1373/clinchem.2011.173138
Commentaries
Commentary
Scott W Sharkey
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 43–44, https://doi.org/10.1373/clinchem.2011.176289
Commentary
Jordi Ordonez-Llanos
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Page 44, https://doi.org/10.1373/clinchem.2011.176297
Mini-Reviews
Biomarkers in Cardiovascular Clinical Trials: Past, Present, Future
Sharif A Halim and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 45–53, https://doi.org/10.1373/clinchem.2011.165787
Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays
Fred S Apple and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 54–61, https://doi.org/10.1373/clinchem.2011.165795
Reviews
Use of Natriuretic Peptides to Guide and Monitor Heart Failure Therapy
A Mark Richards and Richard W Troughton
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 62–71, https://doi.org/10.1373/clinchem.2011.165704
Biomarkers and Cardiovascular Risk Assessment for Primary Prevention: An Update
Lauren G Gilstrap and Thomas J Wang
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 72–82, https://doi.org/10.1373/clinchem.2011.165712
B-Type Natriuretic Peptide: From Posttranslational Processing to Clinical Measurement
Jens P Goetze
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 83–91, https://doi.org/10.1373/clinchem.2011.165696
Genomewide Association Studies in Cardiovascular Disease—An Update 2011
Tanja Zeller and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 92–103, https://doi.org/10.1373/clinchem.2011.170431
9p21 and the Genetic Revolution for Coronary Artery Disease
Robert Roberts and Alexandre F R Stewart
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 104–112, https://doi.org/10.1373/clinchem.2011.172759
Next Steps in Cardiovascular Disease Genomic Research—Sequencing, Epigenetics, and Transcriptomics
Renate B Schnabel and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 113–126, https://doi.org/10.1373/clinchem.2011.170423
Emerging Biomarkers in Heart Failure
Roland R J van Kimmenade and James L Januzzi
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 127–138, https://doi.org/10.1373/clinchem.2011.165720
Metabolomics and Cardiovascular Biomarker Discovery
Eugene P Rhee and Robert E Gerszten
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 139–147, https://doi.org/10.1373/clinchem.2011.169573
Opinions
Troponin Release—Reversible or Irreversible Injury? Should We Care?
Allan S Jaffe and Alan H B Wu
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 148–150, https://doi.org/10.1373/clinchem.2011.173070
Are There Really Biomarkers of Vulnerable Plaque?
Bertil Lindahl
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 151–153, https://doi.org/10.1373/clinchem.2011.165811
Clopidogrel and CYP2C19 Testing: Ready for Clinical Prime Time?
Jean-Sébastien Hulot and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 154–157, https://doi.org/10.1373/clinchem.2011.165829
Point/Counterpoint
Point: Detection of Myocardial Infarction—Is It All Troponin?
Evangelos Giannitsis and Hugo A Katus
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 158–161, https://doi.org/10.1373/clinchem.2011.168575
Counterpoint: Detection of Myocardial Infarction—Is It All Troponin? Role of New Markers
Christian Mueller
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 162–164, https://doi.org/10.1373/clinchem.2011.168583
Point: Put Simply, Standardization of Cardiac Troponin I Is Complicated
Robert H Christenson and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 165–168, https://doi.org/10.1373/clinchem.2011.166140
Counterpoint: Standardization of Cardiac Troponin I Assays Will Not Occur in My Lifetime
Fred S Apple
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 169–171, https://doi.org/10.1373/clinchem.2011.166165
Articles
Lipids, Lipoproteins, and Cardiovascular Risk Factors
Association of Growth Differentiation Factor-15 with Coronary Atherosclerosis and Mortality in a Young, Multiethnic Population: Observations from the Dallas Heart Study
Anand Rohatgi and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 172–182, https://doi.org/10.1373/clinchem.2011.171926
Rosuvastatin, Proprotein Convertase Subtilisin/Kexin Type 9 Concentrations, and LDL Cholesterol Response: the JUPITER Trial
Zuhier Awan and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 183–189, https://doi.org/10.1373/clinchem.2011.172932
Cystatin C and Estimated Glomerular Filtration Rate as Predictors for Adverse Outcome in Patients with ST-Elevation and Non–ST-Elevation Acute Coronary Syndromes: Results from the Platelet Inhibition and Patient Outcomes Study
Axel Åkerblom and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 190–199, https://doi.org/10.1373/clinchem.2011.171520
Circulating Troponin As Measured by a Sensitive Assay for Cardiovascular Risk Assessment in Primary Prevention
David M Leistner and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 200–208, https://doi.org/10.1373/clinchem.2011.174292
Proteomics and Protein Markers
Absolute and Relative Kinetic Changes of High-Sensitivity Cardiac Troponin T in Acute Coronary Syndrome and in Patients with Increased Troponin in the Absence of Acute Coronary Syndrome
Matthias Mueller and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 209–218, https://doi.org/10.1373/clinchem.2011.171827
Influence of Population Selection on the 99th Percentile Reference Value for Cardiac Troponin Assays
Paul O Collinson and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 219–225, https://doi.org/10.1373/clinchem.2011.171082
Midregional Proadrenomedullin for Prediction of Cardiovascular Events in Coronary Artery Disease: Results from the AtheroGene Study
Philipp S Wild and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 226–236, https://doi.org/10.1373/clinchem.2010.157842
Diagnostic Accuracy of Plasma Glial Fibrillary Acidic Protein for Differentiating Intracerebral Hemorrhage and Cerebral Ischemia in Patients with Symptoms of Acute Stroke
Christian Foerch and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 237–245, https://doi.org/10.1373/clinchem.2011.172676
Markers of Plaque Instability in the Early Diagnosis and Risk Stratification of Acute Myocardial Infarction
Nora Schaub and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 246–256, https://doi.org/10.1373/clinchem.2011.172940
Role of ST2 in Non–ST-Elevation Acute Coronary Syndrome in the MERLIN-TIMI 36 Trial
Payal Kohli and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 257–266, https://doi.org/10.1373/clinchem.2011.173369
Galectin-3 and the Development of Heart Failure after Acute Coronary Syndrome: Pilot Experience from PROVE IT-TIMI 22
E Wilson Grandin and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 267–273, https://doi.org/10.1373/clinchem.2011.174359
Concordance, Variance, and Outliers in 4 Contemporary Cardiac Troponin Assays: Implications for Harmonization
Jacobus P J Ungerer and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 274–283, https://doi.org/10.1373/clinchem.2011.175059
Troponin T Measurements by High-Sensitivity vs Conventional Assays for Risk Stratification in Acute Dyspnea
Sandra van Wijk and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 284–292, https://doi.org/10.1373/clinchem.2011.175976
Brief Communications
Comparison of Midregional Pro–A-Type Natriuretic Peptide and the N-Terminal Pro–B-Type Natriuretic Peptide for Predicting Mortality and Cardiovascular Events
Kornelis J J van Hateren and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 293–297, https://doi.org/10.1373/clinchem.2011.166348
Biomarkers for Predicting Serious Cardiac Outcomes at 72 Hours in Patients Presenting Early after Chest Pain Onset with Symptoms of Acute Coronary Syndromes
Peter A Kavsak and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 298–302, https://doi.org/10.1373/clinchem.2011.172064
Citation Classic
Aspirin in the Primary Prevention of Myocardial Infarction
Charles H Hennekens
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 303–304, https://doi.org/10.1373/clinchem.2011.164897
Letters to the Editor
Evidence-Based Laboratory Medicine: How Well Do Laboratories Follow Recommendations and Guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) Study
Paul O Collinson and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 305–306, https://doi.org/10.1373/clinchem.2011.171439
Copeptin Adds to High-Sensitivity Troponin T in Rapid Rule Out of Acute Myocardial Infarction
Martin Möckel
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 306–307, https://doi.org/10.1373/clinchem.2011.171058
Copeptin—A Novel Marker in Acute Myocardial Infarction
Stephan von Haehling and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 307–309, https://doi.org/10.1373/clinchem.2011.173658
In Reply
Mahir Karakas and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 309–311, https://doi.org/10.1373/clinchem.2011.175422
High-Sensitivity Cardiac Troponin Assays—Change Is Important
Peter A Kavsak and Allan S Jaffe
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 311–313, https://doi.org/10.1373/clinchem.2011.174755
In Reply
Sally J Aldous and others
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 313–314, https://doi.org/10.1373/clinchem.2011.176305
Clinical Chemist
Unveiling the Right Side
A Heart-to-Heart Talk
Usha Anand
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 315–316, https://doi.org/10.1373/clinchem.2011.168609
Science in the Arts
William Harvey and the Undercurrents of Science
Marek H Dominiczak
Clinical Chemistry, Volume 58, Issue 1, 1 January 2012, Pages 317–318, https://doi.org/10.1373/clinchem.2011.177600
Advertisement
Advertisement